Market Overview

Wedbush Initiates Novavax At Outperform


Analysts at Wedbush initiated coverage on shares of Novavax (NASDAQ: NVAX) with a Outperform rating.

The target price for Novavax is set to $10.

Novavax shares have jumped 43.59% over the past 52 weeks, while the S&P 500 index has gained 17.63% in the same period.

Novavax's shares rose 0.67% to $4.51 in after-hours trading.

Latest Ratings for NVAX

Dec 2020JefferiesInitiates Coverage OnBuy
Nov 2020HC Wainwright & Co.MaintainsBuy
Aug 2020HC Wainwright & Co.MaintainsBuy

View More Analyst Ratings for NVAX
View the Latest Analyst Ratings


Related Articles (NVAX)

View Comments and Join the Discussion!

Posted-In: WedbushInitiation Analyst Ratings

Latest Ratings

SLABMorgan StanleyInitiates Coverage On143.0
QTSRaymond JamesUpgrades74.0
EQIXRaymond JamesUpgrades835.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at